Literature DB >> 26656780

Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations.

Nicole A Hawkins1, Jennifer A Kearney2.   

Abstract

Mutations in voltage-gated sodium channel genes cause several types of human epilepsies. Often, individuals with the same sodium channel mutation exhibit diverse phenotypes. This suggests that factors beyond the primary mutation influence disease severity, including genetic modifiers. Mouse epilepsy models with voltage-gated sodium channel mutations exhibit strain-dependent phenotype variability, supporting a contribution of genetic modifiers in epilepsy. The Scn2a(Q54) (Q54) mouse model has a strain-dependent epilepsy phenotype. Q54 mice on the C57BL/6J (B6) strain exhibit delayed seizure onset and improved survival compared to [B6xSJL/J]F1.Q54 mice. We previously mapped two dominant modifier loci that influence Q54 seizure susceptibility and identified Hlf (hepatic leukemia factor) as a candidate modifier gene at one locus. Hlf and other PAR bZIP transcription factors had previously been associated with spontaneous seizures in mice thought to be caused by down-regulation of the pyridoxine pathway. An Hlf targeted knockout mouse model was used to evaluate the effect of Hlf deletion on Q54 phenotype severity. Hlf(KO/KO);Q54 double mutant mice exhibited elevated frequency and reduced survival compared to Q54 controls. To determine if direct modulation of the pyridoxine pathway could alter the Q54 phenotype, mice were maintained on a pyridoxine-deficient diet for 6 weeks. Dietary pyridoxine deficiency resulted in elevated seizure frequency and decreased survival in Q54 mice compared to control diet. To determine if Hlf could modify other epilepsies, Hlf(KO/+) mice were crossed with the Scn1a(KO/+) Dravet syndrome mouse model to examine the effect on premature lethality. Hlf(KO/+);Scn1a(KO/+) offspring exhibited decreased survival compared to Scn1a(KO/+) controls. Together these results demonstrate that Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations and that modulation of the pyridoxine pathway can also influence phenotype severity.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Epilepsy; Genetics; Mouse model; Seizure; Voltage-gated sodium channel

Mesh:

Substances:

Year:  2015        PMID: 26656780      PMCID: PMC4698075          DOI: 10.1016/j.eplepsyres.2015.11.016

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  15 in total

Review 1.  Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects.

Authors:  Miriam H Meisler; Janelle E O'Brien; Lisa M Sharkey
Journal:  J Physiol       Date:  2010-03-29       Impact factor: 5.182

2.  Antiepileptic activity of preferential inhibitors of persistent sodium current.

Authors:  Lyndsey L Anderson; Christopher H Thompson; Nicole A Hawkins; Ravi D Nath; Adam A Petersohn; Sridharan Rajamani; William S Bush; Wayne N Frankel; Carlos G Vanoye; Jennifer A Kearney; Alfred L George
Journal:  Epilepsia       Date:  2014-05-23       Impact factor: 5.864

Review 3.  Pyridoxal phosphate-dependent enzymes.

Authors:  R A John
Journal:  Biochim Biophys Acta       Date:  1995-04-27

4.  Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channel Scn2a.

Authors:  Sarah K Bergren; Shu Chen; Andrzej Galecki; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2005-10-19       Impact factor: 2.957

5.  Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy.

Authors:  Frank H Yu; Massimo Mantegazza; Ruth E Westenbroek; Carol A Robbins; Franck Kalume; Kimberly A Burton; William J Spain; G Stanley McKnight; Todd Scheuer; William A Catterall
Journal:  Nat Neurosci       Date:  2006-08-20       Impact factor: 24.884

6.  Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.

Authors:  Nicole A Hawkins; Melinda S Martin; Wayne N Frankel; Jennifer A Kearney; Andrew Escayg
Journal:  Neurobiol Dis       Date:  2010-12-13       Impact factor: 5.996

7.  Voltage-gated potassium channel KCNV2 (Kv8.2) contributes to epilepsy susceptibility.

Authors:  Benjamin S Jorge; Courtney M Campbell; Alison R Miller; Elizabeth D Rutter; Christina A Gurnett; Carlos G Vanoye; Alfred L George; Jennifer A Kearney
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-14       Impact factor: 11.205

8.  Strain- and age-dependent hippocampal neuron sodium currents correlate with epilepsy severity in Dravet syndrome mice.

Authors:  Akshitkumar M Mistry; Christopher H Thompson; Alison R Miller; Carlos G Vanoye; Alfred L George; Jennifer A Kearney
Journal:  Neurobiol Dis       Date:  2014-01-14       Impact factor: 5.996

9.  Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.

Authors:  Sarah K Bergren; Elizabeth D Rutter; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

Review 10.  Vitamin B6 dependent seizures.

Authors:  Barbara Plecko; Sylvia Stöckler
Journal:  Can J Neurol Sci       Date:  2009-08       Impact factor: 2.104

View more
  20 in total

1.  CaMKII modulates sodium current in neurons from epileptic Scn2a mutant mice.

Authors:  Christopher H Thompson; Nicole A Hawkins; Jennifer A Kearney; Alfred L George
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

2.  Potentiating α2 subunit containing perisomatic GABAA receptors protects against seizures in a mouse model of Dravet syndrome.

Authors:  Toshihiro Nomura; Nicole A Hawkins; Jennifer A Kearney; Alfred L George; Anis Contractor
Journal:  J Physiol       Date:  2019-05-20       Impact factor: 5.182

3.  Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome.

Authors:  Jeffrey D Calhoun; Nicole A Hawkins; Nicole J Zachwieja; Jennifer A Kearney
Journal:  Epilepsia       Date:  2017-05-28       Impact factor: 5.864

4.  Phenotypic and Genotypic Characteristics of SCN1A Associated Seizure Diseases.

Authors:  Chunhong Chen; Fang Fang; Xu Wang; Junlan Lv; Xiaohui Wang; Hong Jin
Journal:  Front Mol Neurosci       Date:  2022-04-28       Impact factor: 5.639

5.  The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome.

Authors:  Lyndsey L Anderson; Peter T Doohan; Nicole A Hawkins; Dilara Bahceci; Sumanta Garai; Ganesh A Thakur; Jennifer A Kearney; Jonathon C Arnold
Journal:  Neuropharmacology       Date:  2021-11-22       Impact factor: 5.273

6.  Gene expression profiling in a mouse model of Dravet syndrome.

Authors:  Nicole A Hawkins; Jeffrey D Calhoun; Alexandra M Huffman; Jennifer A Kearney
Journal:  Exp Neurol       Date:  2018-10-19       Impact factor: 5.330

7.  Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a.

Authors:  Jeffrey D Calhoun; Nicole A Hawkins; Nicole J Zachwieja; Jennifer A Kearney
Journal:  Epilepsia       Date:  2016-04-25       Impact factor: 5.864

8.  Effects of SCN1A and SCN2A polymorphisms on responsiveness to valproic acid monotherapy in epileptic children: A protocol for systematic review and meta-analysis.

Authors:  Zhuangfei Wen; Jiang Chen; Bin Zhu; Yan Lu; Lijiao Chen
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

9.  The Heat Sensing Trpv1 Receptor Is Not a Viable Anticonvulsant Drug Target in the Scn1a +/- Mouse Model of Dravet Syndrome.

Authors:  Vaishali Satpute Janve; Lyndsey L Anderson; Dilara Bahceci; Nicole A Hawkins; Jennifer A Kearney; Jonathon C Arnold
Journal:  Front Pharmacol       Date:  2021-05-17       Impact factor: 5.810

10.  The K328M substitution in the human GABAA receptor gamma2 subunit causes GEFS+ and premature sudden death in knock-in mice.

Authors:  Shimian Qu; Chengwen Zhou; Rachel Howe; Wangzhen Shen; Xuan Huang; Mackenzie Catron; Ningning Hu; Robert L Macdonald
Journal:  Neurobiol Dis       Date:  2021-02-11       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.